A Phase I/II Study of Twice Weekly Ixazomib Plus Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma by Nadeem, Omar, Redd, Robert A., Bayliss, Trevor J., Barth, Peter, Laubach, Jacob, Mo, Clifton C., Bianchi, Giada, Masone, Kelly, Griffin, Kyle, Issokson, Lindsay, Barrell, Anna, Doherty, Randi, Mailand, Deborah, Distaso, Alexandra, Patches, Sarah, Goodrich, Kathryn, Oneill, Kathleen, Sanchorawala, Vaishali, Shune, Leyla O., Richardson, Paul G.

Get full text